GLAB — Gemina Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- CA$78.30m
- CA$79.72m
Annual cashflow statement for Gemina Laboratories, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.834 | -4.73 | -5.98 | -5.22 |
| Depreciation | ||||
| Non-Cash Items | 0.363 | 0.706 | 0.403 | 0.616 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.14 | 0.113 | 1.02 | 1.26 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Cash from Operating Activities | -0.319 | -3.87 | -4.51 | -3.24 |
| Capital Expenditures | — | -0.01 | -0.08 | -0.041 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | 0.014 | 0.018 | -0.425 | — |
| Sale of Business | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 0.014 | 0.008 | -0.505 | -0.041 |
| Financing Cash Flow Items | 0.512 | 1.59 | 2.78 | -0.111 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 1.19 | 4.14 | 3.94 | 3.2 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 0.882 | 0.274 | -1.07 | -0.082 |